Auna S.A. Q2 2026 Earnings Call Summary
Auna S.A. released results for the second quarter of 2026, showing consolidated revenue growth of 9% fueled by a strategic shift toward higher-complexity service offerings. The company achieved a 20% sequential increase in oncology treatments in Mexico, reflecting its focus on specialized medical services across its operating regions.
Adjusted EBITDA declined 9% during the period, primarily attributable to temporary margin pressures stemming from investments in medical leadership talent in Mexi
Read more »